Analysis of facilitation of HERG current by a class III anti-arrhythmic agent, nifekalant

被引:0
|
作者
Iwata, Miki
Hosaka, Yukio
Kamiya, Narutoshi
Kinoshita, Kengo
Inanobe, Atsushi
Nakamura, Haruki
Kurachi, Yoshihisa
机构
[1] Osaka Univ, Sch Med, Dept Pharmacol, Div Mol Cell Pharmacol, Osaka 5650871, Japan
[2] Niigata Univ, Grad Sch Med & Dent Sci, Div Cardiol, Niigata 9508510, Japan
[3] Kobe Univ, Grad Sch Med, Dept CGI, Kobe, Hyogo 6500047, Japan
[4] Univ Tokyo, Inst Med Sci, Tokyo 1088639, Japan
[5] Osaka Univ, Inst Prot Res, Lab Prot Informat, Osaka 5650871, Japan
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:193P / 193P
页数:1
相关论文
共 50 条
  • [21] LORCAINIDE - ANTI-ARRHYTHMIC AGENT FOR VENTRICULAR ARRHYTHMIAS
    MYBURGH, DP
    GOLDMAN, AP
    SCHAMROTH, JM
    SOUTH AFRICAN MEDICAL JOURNAL, 1980, 57 (07): : 236 - 239
  • [22] THE IDEAL ANTI-ARRHYTHMIC AGENT - DOES IT EXIST
    NAGER, F
    SCHWEIZERISCHE RUNDSCHAU FUR MEDIZIN PRAXIS, 1980, 69 (26): : 897 - 901
  • [23] The Efficacy of Class III Anti-arrhythmic Drugs in 3D Canine Atrial Models: Is the Blockade of IKCa Pro- or Anti-arrhythmic?
    Varela, Marta
    Dar, Purwa
    Hancox, Jules C.
    Aslanidi, Oleg V.
    2017 COMPUTING IN CARDIOLOGY (CINC), 2017, 44
  • [24] D-SOTALOL - A NEW CLASS-III ANTI-ARRHYTHMIC DRUG
    TAGGART, P
    SUTTON, P
    DONALDSON, R
    CLINICAL SCIENCE, 1985, 68 : P43 - P44
  • [25] Consequences of atrial electrical remodeling for the anti-arrhythmic action of class IC and class III drugs
    Duytschaever, A
    Blaauw, Y
    Allessie, A
    CARDIOVASCULAR RESEARCH, 2005, 67 (01) : 69 - 76
  • [26] hERG1 channel activators: A new anti-arrhythmic principle
    Grunnet, Morten
    Hansen, Rie Schultz
    Olesen, Soren-Peter
    PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2008, 98 (2-3): : 347 - 362
  • [27] Comparison of pro-arrhythmic effects of several class III anti-arrhythmic drugs in rabbit Purkinje fibres
    Sallé, L
    Legrand, JC
    Ducroq, J
    Rouet, R
    Ducouret, P
    Gérard, JL
    JOURNAL OF PHYSIOLOGY-LONDON, 2002, 544 : 59P - 59P
  • [28] CLINICAL-STUDY OF THE ANTI-ARRHYTHMIC AGENT MEXITIL
    KIPSHIDZE, NN
    CHAPIDZE, GE
    DZHANDZHGAVA, SM
    KARDIOLOGIYA, 1980, 20 (10) : 100 - 102
  • [29] PHARMACOLOGICAL STUDIES ON DROXICAINIDE, A NEW ANTI-ARRHYTHMIC AGENT
    ABERG, G
    EKENSTAM, BA
    SMITH, E
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1983, 33-1 (05): : 706 - 710
  • [30] Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches
    Savelieva, Irina
    Camm, John
    EUROPACE, 2008, 10 (06): : 647 - 665